Oxaceprol Sustained Release Tablets 600 Mg – OXIVANT 600 SR Tablets
Composition – Oxaceperol 600mg Sustained Release
Description:
Oxaceprol Sustained Release Tablets 600 Mg contains Oxaceprol, an advanced anti-inflammatory agent known for its ability to inhibit leukocyte adhesion and inflammatory mediator activity. It is commonly used in inflammatory joint conditions and certain respiratory inflammatory disorders. By reducing tissue inflammation and improving microcirculation, it helps relieve pain, swelling, and stiffness while supporting tissue recovery.
Key Point:
1. Novel Anti-Inflammatory Mechanism – Targets Root Cause of Inflammation by Inhibiting leukocyte adhesion and migration, helping control inflammatory processes.
2. Improves Joint Mobility – Helps reduce cartilage degradation, reduces pain, stiffness, and enhances flexibility in joints.
3. Respiratory Inflammation Support – Beneficial in inflammatory respiratory conditions by reducing mucosal inflammation.
4. Sustained Release Advantage – Provides prolonged effect with consistent symptom relief.
5. Well-Tolerated Therapy – Suitable for long-term management of chronic joint conditions.
Targeted Specialties:
• Orthopedicians
• Rheumatologists
• General Physicians
• Internal Medicine Specialists
Disclaimer
To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion.










